<h1>Sattva Sukun Lifecare Approves Key Director Appointments, Proposes Name Change and MOA Alteration</h1>
The Board of Directors of Sattva Sukun Lifecare Ltd., formerly Mayukh Dealtrade Limited, approved several significant operational and governance changes during a meeting held on June 30, 2026. These actions include the regularization of two new directors, approval for a corporate name change, and material amendments to the company’s Memorandum of Association (MOA).
The board members reviewed and sanctioned the appointments of Mr. Sachin Bhanubhai Manseta and Mr. Chirag Dedhia as part of the restructuring and growth planning for the company. Both directorial positions are subject to approval by the shareholders at the forthcoming General Meeting.
Mr. Sachin Bhanubhai Manseta has been regularized as a Non-Executive Independent Director, effective from July 22, 2026, for a term of five years. Mr. Dedhia, who is identified as a finance professional with an M.Sc. in Finance from the University of Surrey, was approved as a Non-Executive Non-Independent Director, also set to commence on July 22, 2026, for a five-year term.
Details regarding the newly appointed directors are provided below:
| Director Name | Designation | Effective Date | Term Length | Key Disclosure |
|---|---|---|---|---|
| Sachin Bhanubhai Manseta | Non-Executive Independent Director | July 22, 2026 | 5 years | Has no relationship with KMP/Promoters. Holds multiple directorships across various private limited entities. |
| Chirag Dedhia | Non-Executive Non-Independent Director | July 22, 2026 | 5 years | Is a finance professional. His companies include Truestar Enterprise Private Limited and Yummzo Snacks And Drinks Llp. |
In addition to the directorial appointments, the board considered and approved the proposal for the company’s name change. The current name, Sattva Sukun Lifecare Limited, is proposed to be changed to one of several options: Tavexia Lifecare Limited, Trumaxa Lifecare Limited, Trustarex Lifecare Limited, or Tradamex life care limited. This change is contingent upon approval by the Central Registration Centre (CRC) and subsequent shareholder approval.
The board also approved the alteration of the Object Clause of the Memorandum of Association, subject to regulatory and shareholder approvals. The alterations aim to expand the company's operational scope significantly.
The proposed changes to the MOA introduce several new business areas beyond the existing core activities in chemicals and finished dosage forms. These include:
- General Trade: Operating as general merchants, traders, international trade consultants, and export houses.
- Service Provision: Providing contract research organization (CRO), contract development and manufacturing organization (CDMO), and contract research and manufacturing services (CRAMS).
- R&D Focus: Establishing research and development centers, laboratories, and pilot plants, and acquiring intellectual property rights such as patents and trademarks.
The meeting also covered the approval of the notice for an Extra-Ordinary General Meeting (EOGM), which is scheduled to be held via Video Conferencing (VC). Mr. Brajesh Gupta, a practicing Company Secretary, was appointed as the Scrutinizer for conducting the E-voting process for this EOGM.
The Board meeting commenced at 01:35 P.M. and concluded at 02:15 P.M.
Stock Price Movement
As of 14:18, Sattva Sukun Lifecare Ltd is currently priced at ₹0.75, reflecting zero percentage change for the day. The stock traded within a tight intraday range, finding its low at ₹0.75 and peaking at ₹0.77.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.